Brainstorm-Cell Therapeutics Company

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI), is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders such as ALS (Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s disease (PD).
Industry: Loss of Proteostasis
Headquarters: United States
Visit Website
Register and Claim Ownership